SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001764013-20-000031
Filing Date
2020-09-04
Accepted
2020-09-04 17:03:24
Documents
1
Period of Report
2020-09-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159925338889934.html 4  
1 FORM 4 wf-form4_159925338889934.xml 4 4011
  Complete submission text file 0001764013-20-000031.txt   5452
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address
Elliott Michael James (Reporting) CIK: 0001822515 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38906 | Film No.: 201162420